Abiraterone With Low-Dose Prednisone in Patients With Prostate Cancer

June 22, 2015
Joseph F. Renzulli, II, MD, FACS

Joseph F. Renzulli, II, MD, FACS, assistant professor of Surgery, (Urology), Alpert Medical School, Brown University, discusses a phase II study that examined the use of abiraterone acetate with low-dose prednisone in patients with prostate cancer.